6.
De Spiegeleer A, Descamps A, Govindarajan S, Coudenys J, Van der Borght K, Hirmz H
. Bacterial Quorum-Sensing Peptides as Immune Modulators Present in Systemic Circulation. Biomolecules. 2023; 13(2).
PMC: 9953703.
DOI: 10.3390/biom13020296.
View
7.
Ankudavicius V, Nikitina D, Lukosevicius R, Tilinde D, Salteniene V, Poskiene L
. Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients. Int J Mol Sci. 2024; 25(4).
PMC: 10889071.
DOI: 10.3390/ijms25042323.
View
8.
Dadgar-Zankbar L, Elahi Z, Shariati A, Khaledi A, Razavi S, Khoshbayan A
. Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance. Cell Commun Signal. 2024; 22(1):547.
PMC: 11566256.
DOI: 10.1186/s12964-024-01909-y.
View
9.
Gao Z, Guo B, Gao R, Zhu Q, Qin H
. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015; 6:20.
PMC: 4313696.
DOI: 10.3389/fmicb.2015.00020.
View
10.
Myung S, Kim Y, Ju W, Choi H, Bae W
. Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials. Ann Oncol. 2009; 21(1):166-79.
DOI: 10.1093/annonc/mdp286.
View
11.
Bars-Cortina D, Ramon E, Rius-Sansalvador B, Guino E, Garcia-Serrano A, Mach N
. Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. BMC Genomics. 2024; 25(1):730.
PMC: 11285316.
DOI: 10.1186/s12864-024-10621-7.
View
12.
Ai B, Mei Y, Liang D, Wang T, Cai H, Yu D
. Uncovering the special microbiota associated with occurrence and progression of gastric cancer by using RNA-sequencing. Sci Rep. 2023; 13(1):5722.
PMC: 10082026.
DOI: 10.1038/s41598-023-32809-9.
View
13.
Gilbert J, Blaser M, Caporaso J, Jansson J, Lynch S, Knight R
. Current understanding of the human microbiome. Nat Med. 2018; 24(4):392-400.
PMC: 7043356.
DOI: 10.1038/nm.4517.
View
14.
Yin X, Ye T, Chen H, Liu J, Mu X, Li H
. The microbiome compositional and functional differences between rectal mucosa and feces. Microbiol Spectr. 2024; 12(8):e0354923.
PMC: 11302734.
DOI: 10.1128/spectrum.03549-23.
View
15.
Xu W, Zhang Y, Chen D, Huang D, Zhao Y, Hu W
. Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis. Gut Pathog. 2024; 16(1):50.
PMC: 11438217.
DOI: 10.1186/s13099-024-00640-w.
View
16.
Qiao Y, Mei J, Ma Z
. Species diversity and network diversity in the human lung cancer tissue microbiomes. FEMS Microbiol Lett. 2024; 371.
DOI: 10.1093/femsle/fnae087.
View
17.
Koca D, Abedi-Ardekani B, LeMaoult J, Guyon L
. Peritumoral tissue (PTT): increasing need for naming convention. Br J Cancer. 2024; 131(7):1111-1115.
PMC: 11443153.
DOI: 10.1038/s41416-024-02828-y.
View
18.
Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S
. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel). 2019; 11(1).
PMC: 6356461.
DOI: 10.3390/cancers11010038.
View
19.
Jin L, Zhou Y
. Crucial role of the pentose phosphate pathway in malignant tumors. Oncol Lett. 2019; 17(5):4213-4221.
PMC: 6444344.
DOI: 10.3892/ol.2019.10112.
View
20.
Dong T, Gupta A
. Influence of Early Life, Diet, and the Environment on the Microbiome. Clin Gastroenterol Hepatol. 2018; 17(2):231-242.
PMC: 6422042.
DOI: 10.1016/j.cgh.2018.08.067.
View